Tina Vilsbøll
@TinaVilsb
Followers
401
Following
169
Media
0
Statuses
35
Professor of endocrinology, clinician scientist, Steno Diabetes Center Copenhagen, Gentofte Hospital, University of Copenhagen, Denmark
Joined September 2020
📢#EASD2024 - Full programme and abstracts are now online! 🔎Discover the wealth of topics waiting for you in Madrid, from exciting basic to breaking clinical #diabetes #science! Register before 17 July to benefit from exclusive rates. https://t.co/H9AP4bMRsN
1
12
36
New exciting data for España? Make history. Consider sharing your late breaking breakthrough in Madrid! #diabetes #EASD2024
#EASD2024 - Late-breaking abstract submission! For the first time in 60 years history of EASD Annual Meetings, we'll be opening a late-breaking abstract submission from 3 to 17 June '24. Be prepared and we look forward to receiving latest results from your #diabetes #research
0
3
15
#EASD2024 - Programme at a glance now available! Have a look👀 https://t.co/H9AP4bMRsN Submit your abstract to share your #diabetes #research, your contributions are essential in shaping the programme. https://t.co/VYeVcjTkq9
1
24
54
🏆 #EASD2024 awards - Who's your candidate for the Claude Bernard Prize 2024?🤔 Awarded in recognition of an individual's innovative #leadership and lifetime achievements in #diabetes #research. It's time to submit your nominations!👉 https://t.co/g4VPHgoNc1
0
2
6
Early morning start at the @EASDnews Board meeting in Düsseldorf @TinaVilsb @MadderJules @professorcm
3
3
49
📢 Call for applications - #EFSD and @LillyDiabetesIn Young Investigator Research Award Programme For innovative #research by early career scientists in the fields of #diabetes and its complications, and to promote excellence in medical #education. https://t.co/mujDkFypEQ
0
16
29
#Overvægt i graviditeten kan påvirke barnets hjerte allerede i fostertilværelsen. Et nyt studie undersøger, om livsstilsændringer og vægttab hos mor inden graviditeten kan mindske forandringer på den nyfødtes hjerte 👉 https://t.co/II9bc3RJjW
#sundhed #forskning @1A_Andersen
0
2
10
We're excited to announce our 2023 Special Issue: Incretins in Metabolic Disease: Pathophysiology and Therapy. Including 8 reviews summarising up-to-date knowledge on #incretins, from basic biology & treatment modalities to socioeconomic barriers to uptake https://t.co/TyAdMyz3ak
1
25
80
The latest in the @EASDnews @DiabetologiaJnl forthcoming 2023 GL.P-1 issue #obesity #NAFLD #NASH @TinaVilsb
https://t.co/RVT0K53fw7.
#Diabetes #T2D
1
23
62
Vi søger en #Cheflæge til den nyetablerede "Afd. for Diabetesbehandling" på @Stenodiabetes. Fokus på at udvikle innovative og progressive #patientforløb, #digitalisering, #præcisionsmedicin- og udvikling af et af Europas største #børnediabeteshospitaler. https://t.co/sQd5L5y7aN
0
7
16
Wow! Masterfully presented Banting Lecture by Prof Matthias Tschop!! Took us thru 30yr journey to arrive at multireceptor agonism to treat obesity. Each step marked by healthy skepticism. Agonism and not antagonism. Future is bright! #ADA2023 #ADARME @MatthiasTschop thank you!
1
20
66
Using implantable loop recorders and CGMs, Dr. @PHagelqvist captured 1-year data on glycaemia and heart rythm in 30 individuals with #T1D and show that acute hypo- and hyperglycaemia during daytime may increase the risk of arrhythmias💗 https://t.co/CdX2sN4vT1
@kellyclose
1
3
8
🚨 2 weeks to go before the #EASD2023 abstract submission deadline! 🗓️ 1 April 2023, 18:00 hrs CEST Don't miss your chance to share your #research and insights with the #diabetes community. https://t.co/OiWbmeqMTn We're looking forward to your contributions.
0
10
12
One can never have enough glucagon-new perspectives from the experts #diabetes #obesity #NASH @UCPH_Research @Filip_Knop @NatureRevEndo
0
31
112
@Christi04644231 defending her PhD thesis “On the role of glycaemia in cardiac arrythmias and function in type 1 diabetes”🤩👏🏼💥 Two published and 1 unpublished manuscript⚡️ https://t.co/37PKRDD84F
https://t.co/ibRLCSWEeo Link to the full thesis here: https://t.co/tKyT8i8VPJ
0
3
7
Risk of sudden cardiac death⬆️x 10 in #T1D. Hypo prolongs QTc interval (risk factor for fatal cardiac arrythmias). Does it matter how you recover (to hyper- vs. euglycemia)? @Christi04644231: "No, but prolonged QTc interval is sustained during recovery" https://t.co/Ahum0WjYuR
0
9
30
Use of glucose-lowering medication is changing rapidly - and it's becoming increasingly complex!💊 Want proof? Check out our new paper providing all the details on the real-world use of these drugs over the last 20 years! Link: https://t.co/Y3tGYtrFJa
#diabetes #epitwitter
0
4
23
📢 It's time again to prepare your abstract submissions for #EASD2023! The submission system is now open and you are invited to submit your #abstracts to share your #research at #EASD2023
https://t.co/OiWbmeqMTn
#diabetes #science #conference
0
18
32
Diabetes makes the heart work harder: @TinaVilsb, @Filip_Knop et al. @HerlevGentofte explore the link between #hypoglycemia, glycemic variability and #cardiovasculardisease in #type1diabetes – picked by @simonrheller & Ahmed Iqbal. https://t.co/vaPYywdkT3
0
2
4
Big congrats to @PHagelqvist, a true master of glucose clamps, for publishing his first PhD study showing that exercise-related hypoglycemia [also] induces prolongations of QTc- and T-peak to T-end intervals in #type1diabetes. Ventricular arrhythmia risk. https://t.co/arD8J6XqQD
0
10
32